Grace Therapeutics (GRCE) Share-based Compensation (IS) (2011 - 2026)
Grace Therapeutics' Share-based Compensation (IS) was $105,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 65.2% from $302,000 a year earlier and down 42.3% from the prior quarter.
Grace Therapeutics (GRCE) Share-based Compensation (IS) (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Grace Therapeutics' Share-based Compensation (IS) was $602,000 through Jun 30, 2026, down 24.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $798,000, up 9.3% from FY2025.
- In earlier fiscal years, Share-based Compensation (IS) was $730,000 in FY2025 (-20.0%) and $913,000 in FY2024.
- The fiscal Q1 2027 figure marks the lowest quarterly Share-based Compensation (IS) since fiscal Q1 2018.
- Compared with a year earlier, Share-based Compensation (IS) was higher in three of the last five quarters, with an average decline of 5.6%.
- Per Business Quant data, GRCE's Share-based Compensation (IS) in the three fiscal quarters before Q1 2027 was $182,000 (Q4 2026), $109,000 (Q3 2026) and $206,000 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | - |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | 197,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105,000.00 |
| Mar 31, 2026 | 182,000.00 |
| Dec 31, 2025 | 109,000.00 |
| Sep 30, 2025 | 206,000.00 |
| Jun 30, 2025 | 302,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | 202,000.00 |
| Jun 30, 2024 | 238,000.00 |
| Dec 31, 2018 | 254,560.25 |
| Sep 30, 2018 | 249,380.44 |
| Jun 30, 2018 | 194,564.91 |
| Mar 31, 2018 | 212,042.70 |
| Dec 31, 2017 | 259,756.94 |
| Sep 30, 2017 | 235,234.87 |
| Jun 30, 2017 | 26,773.80 |
| Nov 30, 2016 | 155.00 |
| Aug 31, 2016 | 210,000.00 |
| May 31, 2016 | 64,000.00 |
| Feb 29, 2016 | 108,000.00 |
Grace Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();